F. De Valle

Immunochemotherapy with Rituximab Improves Molecular CR Rate and Outcome In CD20+ B-Lineage Standard and High Risk Patients; Results of 263 CD20+ Patients Studied Prospectively In GMALL Study 07/2003

Dieter Hoelzer, Andreas Huettmann, Felix Kaul et al. · Blood · 2010 · 83 citations

Life Sciences, Immunology, Oncology +12

Serum-free generation and quantification of functionally active Leukemia-derived DC is possible from malignant blasts in acute myeloid leukemia and myelodysplastic syndromes

Stefanie Kufner, Richard Fleischer, Tanja Kroell et al. · Cancer Immunology Immunotherapy · 2005 · 37 citations · Full text

Medicine, Hematology, Oncology +11

Leukaemia‐Derived Dendritic Cells Can Be Generated From Blood or Bone Marrow Cells From Patients With Myelodysplasia: A Methodological Approach Under Serum‐Free Culture Conditions

Stefanie Kufner, Horst Zitzelsberger, Tanja Kroell et al. · Scandinavian Journal of Immunology · 2005 · 28 citations · Full text

Life Sciences, Hematology, Immunology +12

Leukemia‐Derived Dendritic Cells can be Generated from Blood or Bone Marrow Cells from Patients with Acute Myeloid Leukaemia: A Methodological Approach under Serum‐Free Culture Conditions

Stefanie Kufner, Horst Zitzelsberger, Tanja Kroell et al. · Scandinavian Journal of Immunology · 2005 · 26 citations · Full text

Life Sciences, Hematology, Immunology +13